PAVmed Inc.: 10-K filed 2018-03-14

Name: PAVmed Inc.: 10-K filed 2018-03-14
Creator: PAVmed Inc.

What PAVmed Inc. reported in its annual report filed 2018-03-14 (fiscal FY 2017): 26 published measures, 52 facts as tagged in accession 0001493152-18-003367.

This filing

Form: 10-K (annual report)
Filed: 2018-03-14
Fiscal period: fiscal FY 2017
Accession: 0001493152-18-003367 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PAVmed Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-12-31	1,639,680	USD
At 2016-12-31	870,419	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-12-31	4,488,037	USD
At 2016-12-31	1,189,486	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2017-12-31	-2,848,357	USD
At 2016-12-31	-319,067	USD
At 2015-12-31	633,918	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-12-31	1,535,022	USD
At 2016-12-31	585,680	USD
At 2015-12-31	767,268	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-9,519,269	USD	365
2016-01-01 to 2016-12-31	-5,650,851	USD	366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	5,301	USD	365
2016-01-01 to 2016-12-31	21,793	USD	366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-12-31	-17,907,611	USD
At 2016-12-31	-7,701,835	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-12-31	16,191	USD
At 2016-12-31	18,000	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	1,048,127	USD	365
2016-01-01 to 2016-12-31	747,365	USD	366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-8,034,119	USD	365
2016-01-01 to 2016-12-31	-5,650,851	USD	366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-12-31	1,623,489	USD
At 2016-12-31	741,170	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	724,684	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-12-31	2,543,769	USD
At 2016-12-31	1,189,486	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-12-31	864,405	USD
At 2016-12-31	949,413	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	8,034,119	USD	365
2016-01-01 to 2016-12-31	5,650,851	USD	366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	2,618,795	USD	365
2016-01-01 to 2016-12-31	1,719,587	USD	366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-12-31	14,551,234	shares
At 2016-12-31	13,330,811	shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2017-12-31	27,094	USD
At 2016-12-31	21,793	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-12-31	10,903	USD
At 2016-12-31	3,793	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-12-31	706,024	USD
At 2016-12-31	240,073	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2017-12-31	88,467	USD
At 2016-12-31	155,490	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-10,398,134	USD	365
2016-01-01 to 2016-12-31	-5,650,851	USD	366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	5,415,324	USD	365
2016-01-01 to 2016-12-31	3,931,264	USD	366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	7,110	USD	365
2016-01-01 to 2016-12-31	3,793	USD	366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-1,485,150	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-12-31	-85,008	USD	365
2016-01-01 to 2016-12-31	877,592	USD	366

Inspect the source

Entity: PAVmed Inc. / CIK 0001624326
Captured: 2026-09-21T17:21:55.016Z
SEC response SHA-256: 7a616ccc5170f5c8d7e67e29e033fac50d9d386fd448dd5cc92765456a56ed2f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001624326.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))